VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2020 | Axitinib plus pembrolizumab in advanced RCC

Michael Atkins, MD, of Georgetown University, Washington, DC, reports long-term efficacy and safety from a phase Ib study investigating the combination of axitinib and pembrolizumab in advanced renal cell carcinoma patients. This video was recorded via an online conference call with the Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter